{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:32:34Z","timestamp":1780547554362,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/ajp.0b013e3182510295","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T07:29:08Z","timestamp":1347434948000},"page":"775-781","source":"Crossref","is-referenced-by-count":30,"title":["Efficacy and Safety of Duloxetine 30 mg\/d in Patients With Fibromyalgia"],"prefix":"10.1097","volume":"28","author":[{"given":"Lesley M.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Pangallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee.","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","article-title":"Cerebrospinal fluid biogenic amine metabolites in fibromyalgiafibrositis syndrome and rheumatoid arthritis.","volume":"35","author":"Russell","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R3-4-20210204","first-page":"95","article-title":"Plasma and urinary catecholamines in primary fibromyalgia: a controlled study.","volume":"19","author":"Yunus","year":"1992","journal-title":"J Rheumatol"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0304-3940(98)00937-9","article-title":"Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients.","volume":"259","author":"Schwarz","year":"1999","journal-title":"Neurosci Lett"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","article-title":"Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.","volume":"7","author":"Basbaum","year":"1984","journal-title":"Annu Rev Neurosci"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0006-8993(93)90210-E","article-title":"The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception.","volume":"616","author":"Clark","year":"1993","journal-title":"Brain Res"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain.","volume":"66","author":"Millan","year":"2002","journal-title":"Prog Neurobiol"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1381612053764805","article-title":"The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.","volume":"11","author":"Bymaster","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.20485","article-title":"A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","article-title":"Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.","volume":"136","author":"Russell","year":"2008","journal-title":"Pain"},{"key":"R14-4-20210204","first-page":"91","article-title":"A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.","volume":"1","author":"Chappell","year":"2009","journal-title":"Int J Gen Med"},{"key":"R15-4-20210204","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory.","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"issue":"suppl 20","key":"R16-4-20210204","first-page":"22","article-title":"The Mini-international Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R19-4-20210204","first-page":"728","article-title":"The Fibromyalgia Impact Questionnaire: development and validation.","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.","volume":"67","author":"Beck","year":"1996","journal-title":"J Pers Assess"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","article-title":"Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDAs pediatric suicidal risk analysis of antidepressants.","volume":"164","author":"Posner","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-005-0304-0","article-title":"A dose-finding study of duloxetine based on serotonin transporter occupancy.","volume":"185","author":"Takano","year":"2006","journal-title":"Psychopharmacology"},{"key":"R25-4-20210204","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","article-title":"Patients perspective on the impact of fibromyalgia.","volume":"73","author":"Arnold","year":"2008","journal-title":"Patient Educ Couns"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10067-009-1203-2","article-title":"Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.","volume":"28","author":"Choy","year":"2009","journal-title":"Clin Rheumatol"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157488608784529189","article-title":"Hepatic effects of duloxetine-I: non-clinical and clinical trial data.","volume":"3","author":"Wernicke","year":"2008","journal-title":"Curr Drug Saf"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002508-201211000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:42:28Z","timestamp":1618033348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-201211000-00004"}},"subtitle":["A Randomized, Double-blind, Placebo-controlled Study"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e3182510295","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}